You have read all your free articles, to continue reading subscribe to read the rest of this content.
Earlier this month Mylan announced that it has completed the settlement of its recommended public offer to the shareholders of Meda Aktiebolag to tender all their shares in Meda to Mylan. The offer was accepted by shareholders holding approximately 94% of the total number of outstanding shares aAlready a subscriber Login…
The Swedish health tech startup plans to use evidence-based methods and clinical research strategies to develop AI algorithms for healthcare. The company is associated to Uppsala University and plans to initiate the first clinical studies in 2019. AlgoDx's most advanced development project involAlready a subscriber Login You have read all your…
The US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Fasenra (benralizumab) for the treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA). EGPA is a rare autoimmune disease that can cause damage to multiple organs and tissues. The FDA grants ODD statAlready a subscriber Login You have…
The Board of Directors of BioInvent International has resolved to issue a directed share issue to Swedish and international institutional investors. Investors in the Directed Share Issue are a number of Swedish and international investors, including new investors such as HBM Healthcare InvestmentAlready a subscriber Login You have read all…
